Biogen Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BIIB Nasdaq 2836 www.biogen.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biogen Inc.

Biogen Announces Board Chair Transition - Feb 11th, 2026 3:00 pm
Biogen Pipeline Advances In Lupus And SMA Reshape Growth Outlook - Feb 10th, 2026 5:09 am
Why Biogen (BIIB) Is Up 8.2% After Mixed 2025 Earnings and Neurology Pipeline Updates – And What's Next - Feb 9th, 2026 11:06 pm
Biogen Sales Execution, Growth Support Long-Term EPS, RBC Says - Feb 9th, 2026 9:40 am
Will These 5 Drug Bigwigs Surpass Q4 Earnings Forecasts? - Feb 9th, 2026 9:38 am
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China - Feb 8th, 2026 7:00 pm
Biogen Hits 52-Week High, Alzheimer's Drug Sales Jump - Feb 8th, 2026 3:31 pm
BIIB Q4 Deep Dive: Pipeline Advances and New Product Launches Offset Legacy Headwinds - Feb 6th, 2026 10:31 pm
Why Biogen Stock Surged Almost 9% Higher on Friday - Feb 6th, 2026 6:07 pm
Biogen’s Nusinersen Data And FDA Review Put Valuation In Focus - Feb 6th, 2026 3:06 pm
How One Drug Heavy-Lifted Biogen's Fourth-Quarter Beat - Feb 6th, 2026 2:09 pm
Biogen Inc (BIIB) Q4 2025 Earnings Call Highlights: Strong Growth in Key Products Amidst ... - Feb 6th, 2026 2:02 pm
Biogen stock pops, Robinhood gets lift as bitcoin ticks up - Feb 6th, 2026 1:48 pm
Biogen Stock Rises Even as Multiple Sclerosis Revenue Tumbles. It Sees Continued Declines in the Portfolio. - Feb 6th, 2026 10:01 am
BIIB Beats on Q4 Earnings & Sales, Stock Gains on Upbeat '26 EPS View - Feb 6th, 2026 9:30 am
Biogen Forecasts 2026 Profit Above Estimates as Shares Climb 30% - Feb 6th, 2026 9:15 am
Biogen (BIIB) Q4 2025 Earnings Call Transcript - Feb 6th, 2026 8:29 am
Biogen Q4 Earnings Call Highlights - Feb 6th, 2026 8:10 am
Biogen (BIIB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Feb 6th, 2026 7:30 am
Biogen Revenue Down as Multiple Sclerosis Sales Slide - Feb 6th, 2026 6:59 am